Alpine Global Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-181,403
| Closed | -$33.3M | – | 446 |
|
|
2021
Q2 | $33.3M | Buy |
181,403
+13,846
| +8% | +$2.54M | 4.54% | 3 |
|
|
2021
Q1 | $25.6M | Buy |
167,557
+162,557
| +3,251% | +$24.9M | 2.46% | 11 |
|
|
2020
Q4 | $781K | Buy |
+5,000
| New | +$781K | 0.16% | 74 |
|
|
2020
Q1 | – | Sell |
-56,238
| Closed | -$6.08M | – | 519 |
|
|
2019
Q4 | $6.08M | Buy |
+56,238
| New | +$6.08M | 1.3% | 10 |
|
|
2017
Q4 | – | Sell |
-1,625
| Closed | -$228K | – | 294 |
|
|
2017
Q3 | $228K | Buy |
+1,625
| New | +$228K | 0.07% | 166 |
|
|
2015
Q3 | – | Sell |
-1,014
| Closed | -$183K | – | 934 |
|
|
2015
Q2 | $183K | Sell |
1,014
-240
| -19% | -$43.3K | 0.03% | 417 |
|
|
2015
Q1 | $217K | Sell |
1,254
-2,868
| -70% | -$496K | 0.07% | 276 |
|
|
2014
Q4 | $763K | Buy |
+4,122
| New | +$763K | 0.14% | 163 |
|